Dane lands top job with beleaguered generics giant after reviving Lundbeck’s fortunes
Israel company expects earnings per share of $4.90-$5.30 on revenue of $23.8bn-$24.5bn
Pharmaceutical acquisition was announced a year ago with $40.5bn price tag
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle
Mylan adopts poison-pill defence and renews commitment to Perrigo deal
Firm bolsters its business of making drugs to treat disease of the central nervous system
Demand will create ‘inexorable upward pressure’ despite efforts by minister to cut the costs
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices